Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

MedPAC Questions Spending But Comes Up Short On Solutions
The Medicare Payment Advisory Commission - an independent group that makes recommendations to Congress on Medicare issues - said in its annual June report that the "government must give doctors and health-care facilities incentives to rein in costs in providing care for the elderly and disabled," the Wall Street Journal reports. The panel, known as MedPAC, raised specific questions about high priced imaging services that encourage doctors to over use them, the possibility of penalizing physicians who provide poor care at high cost with lower payments, and whether to cut payments to private plans that provide Medicare coverage (Zhang, 6/16).
generic viagra online
Anterior Cingulate Cortex: Monitoring The Outcomes Of Others' Decisions
Good decision-making helps us to achieve our goals in a complicated world. Understanding which decisions are successful and which ones fail is important, and learning how other people make decisions is an important way of refining this ability. What happens in the brain when this useful information is withheld? Brain imaging researchers from Royal Holloway University of London (UK) investigated activity in the human brain at the time that volunteers interpreted the successes and failures of their own decisions, or the successes and failures of others" decisions. Crucially, when this important information was withheld, a region of the brain called the Anterior Cingulate Cortex became active in different ways depending on whether the information withheld related to decisions of the person in the scanner, or whether it related to the person that they were monitoring during the experiment. This tells us that this area works in different ways depending on whether gaps in important information relate to ourselves, or whether they relate to others".
News of the day
How Consumers Continue Enjoying Their Favorite Experiences
We"ve all experienced listening to a song until we can"t stand it. A new study in the Journal of Consumer Research may help people continue to enjoy the products and experiences they once loved.
Health Insurance

NexMed Announces Decision For Anti-Fungal Product

NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT® technology, announced the mutual decision with Novartis to terminate the licensing agreement for NM100060, a topically-applied treatment for onychomycosis, commonly known as nail fungus. NexMed entered into the exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, manufacturing and commercialization responsibilities for NM100060. In addition, NexMed also announced that the results from the comparator study of NM100060 vs. Loceryl, a topical nail lacquer currently marketed in Europe, showed comparable safety and efficacy profiles for the two products in patients with mild to moderate toenail fungus. In the post hoc analysis of patients with mild fungus, NM100060 showed higher efficacy, which was consistent with the results from the two Phase 3 pivotal studies completed by Novartis in 2008. However, the study results were insufficient to support filing for marketing approval. Vivian Liu, NexMed"s Chief Executive Officer said, "There were lessons learned from the studies which warrant further development of this product. We decided that NexMed will proceed with potential new licensing discussions. We have already received inquiries from companies with a focus in dermatology who are interested in commencing discussions." NexMed will host a conference call on July 8, 2009, at 9:00 am EDT to update investors. The call can be accessed in the U.S. by dialing 877-407-9205 and outside of the U.S. by dialing 201-689-8054 and asking the conference operator for the NexMed Conference Call. The teleconference replay is available for one week by dialing in the U.S. 877-660-6853 and outside of the U.S. by dialing 201-612-7415. Replay pass codes 286 and 327678 are both required for playback. The conference call will also be Webcast live at URL. The Webcast replay will be available for three months. NexMed


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009